ANTI-CANCER AND ANTI-INFECTIOUS DISEASE COMPOSITIONS AND METHODS FOR USING SAME

Details for Australian Patent Application No. 2003279770 (hide)

Event Publications

26 February 2004 Complete Application Filed

Priority application(s): 60/416,660 01.10.02 US; 60/414,649 01.10.02 US

27 May 2004 Application Open to Public Inspection

Published as AU-A-2003279770

24 August 2006 Amendment Made

The nature of the amendment is: Amend the priority details from 60/416,660 01 Oct 2002 US to 60/414,660 01 Oct 2002 US 2004

1 March 2007 Amendment Made

The nature of the amendment is: Amend co-inventor name from Sloan, David L to Sloane, David L. 2004

26 March 2009 Assignment before Grant

Chiron Corporation The application has been assigned to Novartis Vaccines and Diagnostics, Inc.

5 November 2009 Alteration of Name

The name of the applicant has been altered to Novartis Vaccines and Diagnostics, Inc.

26 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.